You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The company, which launched the technology in September 2019, said in its Q4 earnings release that it received high marks from beta testers.
The firm also has an early-access program for a new amplification strategy that combines 11 HLA genes for typing.
In a retrospective analysis, UK researchers found that long-read sequencing of HLA genes in stem cell transplantation donors and recipients led to better outcomes.
Japanese researchers developed a catalog of HLA alleles that they used to perform a phenome-wide association study of the MHC and about a hundred phenotypes.
The index's 13 percent gain was below the 39 percent surge of 2017 but occurred despite the poor performance of index stocks in December.
The company also said it launched a new comprehensive diagnostic called HeartCare for surveillance of heart transplant patients.
The team used genetic scoring to identify infants without a family history of the disease who had more than a 10 percent risk for developing islet antibodies.
The firm says its Olerup QType test is available on both Roche and Applied Biosystems platforms.
The workflow was cleared by the South Korean Ministry of Food and Drug Safety for the typing of HLA-A, B, C, DRB1, and DQB1 by next-generation sequencing.
The Boston-based startup wants to help individuals interpret their HLA data for ancestry and health, and participate in research studies.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.
In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.